Get started
Author

Serena Marotta

Eltrombopag Added to Immunosuppression in Severe Aplastic Anemia
2022 · Régis Peffault de Latour, Austin Kulasekararaj, et al. · New England Journal of Medicine · 329
PDF
Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT
2019 · Antonio M. Risitano, Serena Marotta, et al. · Frontiers in Immunology · 268
PDF
Incidence, Risk Factors and Outcome of Pre-engraftment Gram-Negative Bacteremia After Allogeneic and Autologous Hematopoietic Stem Cell Transplantation: An Italian Prospective Multicenter Survey
2017 · Corrado Girmenia, Alice Bertaina, et al. · Clinical Infectious Diseases · 175
PDF
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
2021 · Antonio M Risitano, Alexander Röth, et al. · The Lancet Haematology · 122
Twenty years of the Italian Fanconi Anemia Registry: where we stand and what remains to be learned
2015 · A. M. Risitano, S. Marotta, et al. · Haematologica · 79
PDF
Impact of donor age and kinship on clinical outcomes after T-cell–replete haploidentical transplantation with PT-Cy
2020 · Jacopo Mariotti, Anna Maria Raiola, et al. · Blood Advances · 65
PDF
Toward complement inhibition 2.0: Next generation anticomplement agents for paroxysmal nocturnal hemoglobinuria
2018 · Antonio M. Risitano, Serena Marotta · American Journal of Hematology · 61
PDF
Eltrombopag for post-transplant cytopenias due to poor graft function
2019 · Serena Marotta, Luana Marano, et al. · Bone Marrow Transplantation · 59
Combined intensive immunosuppression and eculizumab for aplastic anemia in the context of hemolytic paroxysmal nocturnal hemoglobinuria: a retrospective analysis
2017 · S Pagliuca, A M Risitano, et al. · Bone Marrow Transplantation · 50
Impact of HLA Disparity in Haploidentical Bone Marrow Transplantation Followed by High-Dose Cyclophosphamide
2017 · Anna Maria Raiola, Antonio Risitano, et al. · Transplantation and Cellular Therapy · 50
Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future
2016 · Antonio M. Risitano, Serena Marotta · Seminars in Immunology · 41
Letermovir Prophylaxis for Cytomegalovirus Infection in Allogeneic Stem Cell Transplantation: A Real-World Experience
2021 · Massimo Martino, Annalisa Pitino, et al. · Frontiers in Oncology · 32
PDF
Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients
2015 · Antonio M Risitano, Michael Storek, et al. · Blood · 26
Hematopoietic stem cell transplantation for aplastic anemia and paroxysmal nocturnal hemoglobinuria: current evidence and recommendations
2014 · Serena Marotta, Simona Pagliuca, et al. · Expert Review of Hematology · 17
Therapeutic outcomes using subcutaneous low dose alemtuzumab for acquired bone marrow failure conditions
2017 · Swapna Thota, Bhumika J. Patel, et al. · British Journal of Haematology · 14
Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs
2020 · Domenico Pastore, Benedetto Bruno, et al. · Annals of Hematology · 11
PDF
‘Real-life’ report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO)
2017 · L Giaccone, G Mancini, et al. · Bone Marrow Transplantation · 9
PDF
Acute immune toxicity during anti‐thymocyte globulin: That's CARPA!
2017 · Serena Marotta, Patrizia Ricci, et al. · American Journal of Hematology · 5
PDF
Impact of second-degree related donor on the outcomes of T cell-replete haploidentical transplantation with post-transplant cyclophosphamide
2022 · Jacopo Mariotti, Anna Maria Raiola, et al. · Bone Marrow Transplantation · 4
Gilteritinib as treatment for extra-medullary relapse of FLT3-ITD acute myeloid leukemia FLT3-ITD, after allogeneic haematopoietic stem cell transplantation
2022 · R. Iannotta, M. Celentano, et al. · Leukemia Research Reports · 2
PDF
Eltrombopag Added to Standard Immunosuppressive Treatment Improves Long-Term Outcomes As Front-Line Therapy for Severe Aplastic Anemia: Final 2-Year Analysis of EBMT-Saawp Race Study
2024 · Antonio M Risitano, Simona Iacobelli, et al. · Blood · 1
Post-Transplant Cyclophosphamide versus Anti-Thymocyte Globulin in Patients with Hematological Malignancies Treated with Allogeneic Hematopoietic Stem Cell Transplantation from Haploidentical and Matched Unrelated Donors: A Real-Life Experience
2024 · Bianca Serio, Gabriella Storti, et al. · Hematology Reports · 1
PDF
Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation
2024 · Flavia Antonucci, Serena Marotta, et al. · Frontiers in Hematology · 1
PDF
Eltrombopag for Prolonged Post-Transplant Hyporigenerative Cytopenias
2018 · Luana Marano, Serena Marotta, et al. · Blood · 1
Subcutaneous Low Dose Alemtuzumab: Role As a Salvage Therapy in Immune -Mediated Marrow Failure Conditions
2016 · Swapna Thota, Srinivasa Reddy Sanikommu, et al. · Blood · 1
Works count: 42
Citation count: 1,424
H-index: 14
I10-index: 16
Year
Topic
Type